Oct 11 (Reuters) - Pfizer Inc said a late-stagetrial of its experimental pain drug showed the drug's long-termsafety profile was comparable to those of other similarformulations.
The trial was testing the safety of the drug, called ALO-02,when administered for up to 12 months.
The drug uses a technology that discourages common methodsof drug abuse associated with prescription opioid use.
(Reporting by Esha Dey in Bangalore; Editing by SreejirajEluvangal)
Keywords: PFIZER TRIAL PAINDRUG/